Location: Northeast region of US (NY, NJ, MA, PA)

Full-time Position

Position:

BioMedGPS, a leading strategic advisory and healthcare analytics firm serving the life sciences industry, is seeking a Director of Enterprise Sales with extensive healthcare B2B experience for its SmartTRAK Business Intelligence platform and related products. Applicant must reside in the Northeastern region of the USA for easy access to major accounts.

SmartTRAK is the first business intelligence portal that provides real time data, analytics and curated content by a team of industry experts to help medical device executives make more informed strategic decisions. SmartTRAK is utilized by leading medical device companies within the orthopedic, wound care, regenerative medicine and neuro therapeutic areas. The Director of Sales will be responsible for selling SmartTRAK’s suite of business intelligence solutions to C- suite and other senior level executives, as well as building long term strategic programs and relationships at all levels of the enterprise.

It was a busy year, and SmartTRAK, the leading provider of real-time market data, analysis and advisory services for the orthopedic, wound, regenerative medicine and neuro therapies markets, covered all the key industry happenings in 2019, providing comprehensive industry coverage of the latest trends, news, intel and interviews most important to you.

And if you'd like to stay on top of hot trends and technologies in 2020 in the ortho, wound, regen and neuro markets, make sure to sign up to receive a weekly summary of our latest blog posts.

Here are SmartTRAK's Top 10 blog posts of the past year with two bonus posts, because at SmartTRAK we always strive to deliver more than what's expected!

Elise Wolf, SmartTRAK's Senior Analyst, Computer Assisted Surgery, will be representing SmartTRAK at CAOS International 2019, the 19th Annual Meeting of the  International Society for Computer Assisted Orthopaedic Surgery, to be held in New York, June 19-22 at the Midtown Hilton.

Elise, with bachelor's and master's degrees in bioengineering, designed biologically inspired robots for the Department of Defense at a spin-off of Carnegie Mellon University. After robotics, she transitioned to the medical device industry and has more than 15 years of experience in product development, marketing, and business development consulting in emerging medical device technologies and orthopedics. Elise has worked with BioMedGPS since 2009 as a SmartTRAK Senior Analyst covering orthopedics and Computer-Assisted Surgery.

You can view Elise's intro video below...

Frederique Buntoum (aka Freddy), SmartTRAK's Senior Analyst, Regenerative Medicine, overseeing the Cell Processing, Amniotic Tissue and Joint Fluid modules, will be representing SmartTRAK at TOBI 2019, the Tenth Annual PRP & Regenerative Medicine Symposium in Chicago, IL, June 6-8. 

You can view Freddy's intro video below...

BioMedGPS’s SmartTRAK Senior Analyst for Computer-Assisted Surgery, Elise Wolf, participated as an expert on robotics in a panel discussion entitled “Tech Talk: An Overview of the Growing Role of Additive Manufacturing and Robotic Surgery” at the ODT Forum (Orthopedics Device & Technology Forum) in Memphis, TN on April 11th. The panel, facilitated by Dawn Lissy, President of Empirical Testing, also included spine robotics entrepreneur Mitch Foster, CEO of Mindset Medical and former CEO of Excelsius Surgical, a surgical robotics technology company that was acquired by Globus Medical in 2013. Brian McLaughlin, CEO of Amplify, an additive manufacturing startup specializing in foot and ankle implants, and Chuck Hansford, Director of Advanced Materials Processing at Tecomet, participated in the discussion on additive manufacturing...

Will you be attending AAOS this year? SmartTRAK will be exhibiting (booth #6847) and we’re hoping to schedule a quick meeting to check-in with you and learn how we can better meet your needs. 

We’ll also have several SmartTRAK analysts on-site consulting with customers. Have questions about market numbers or want to know more about the latest technologies on the market? Maybe you have some questions about our latest market recap or where the market is going?

Frederique Buntoum (aka Freddy) has joined BioMedGPS as Senior Analyst, Regenerative Medicine, overseeing the Cell Processing, Amniotic Tissue and Joint Fluid modules. Formerly Senior Manager of Market Insights at Bioventus, Freddy has broad experience in sales, marketing and competitive intelligence. Her passion for market research and uncovering the “why” behind industry developments complements SmartTRAK’s team of domain experts and her thoughtful and keen insights and out-of-the-box perspective on market happenings make her a great addition to the SmartTRAK analyst team.

In addition to her role as an analyst, Freddy will also be assisting with consulting projects and product development initiatives – two key areas that will contribute to BioMedGPS growth in 2019.

Freddy will be representing SmartTRAK at the upcoming AAOS meeting. Please Contact us if you would like to set up a time to meet.

BioMedGPS is proud to feature the top 2018 news and analysis from SmartTRAK’s team of domain experts in the orthopedics, wound care, and neuro therapies markets.

IRVINE, CA (PRWEB) JANUARY 02, 2019

We covered a lot of ground in 2018. Everything from breaking medical device event coverage to interviews with some of the industry's top thought leaders.  We wrote and you read.  Here are the Top Blog Posts of 2018 that garnered the most attention from you and your colleagues.

As a reminder, if you'd like to stay on top of hot trends and technologies in the ortho, wound and neuro markets, make sure to sign up to receive a weekly summary of our latest blog posts.

Without further ado, SmartTRAK's 12 Top Blog Posts of the past year (not just 10, because at SmartTRAK, we always deliver more than expected) 

Pricing pressure continues to dampen the US Joint Fluid market, which experienced a double-digit decline of -9.9% according to SmartTRAK's Financial Dashboard results. While the market continues to expand in terms of the number of patients treated, ASPs have steadily eroded over the past three quarters since the Anthem non-coverage decision kicked in earlier this year. Year-to-date, the US Joint Fluid market slowed significantly, posting negative growth according to SmartTRAK estimates...